Research Abstract
Probucol, a new cholesterol lowering drug.
AI Summary
Key Findings
0:00 / 0:00
0:00 / 0:00
Abstract
The purpose of this investigation was to determine the ability of Dh-581 (Procubol) (See Figure 1) to reduce the level of serum cholesterol for extended periods of time and to maintain the reduction without loss of effectiveness. The effects of DH-581 on triglycerides and the safety and tolerance of daily doses were also assessed.
External References
- PubMed ID:
- 768396
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.